Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person el-Deiry, WS

Class:Id	Person:77151
_displayName	el-Deiry, WS
_timestamp	2003-10-17 02:04:57
firstname	W S
initial	WS
surname	el-Deiry
(author)	[LiteratureReference:69405] WAF1, a potential mediator of p53 tumor suppression. [LiteratureReference:69571] A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. [LiteratureReference:140992] TRAIL and apoptosis induction by TNF-family death receptors [LiteratureReference:517714] Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues [LiteratureReference:5633431] KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene [LiteratureReference:5633440] Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site [LiteratureReference:5675514] Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 [LiteratureReference:8865242] AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
[Change default viewing format]

No pathways have been reviewed or authored by el-Deiry, WS (77151)